Prof. Damara Ortiz (UPMC Children’s Hospital of Pittsburgh, Pittsburgh, PA, USA) joins us for Rare Disease Day to discuss the daily impact that Pompe disease has on patients. Prof. Ortiz discusses how emerging therapies have improved outcomes for children, and how a newborn screening program has been put in place in Pennsylvania to diagnose Pompe disease early and save children’s lives.
Touch Medical Media is supporting Rare Disease Day (28 February 2022) to shine a light on healthcare inequalities for people living with rare diseases, focusing on patient quality of life and the difficulty of diagnosing patients early.
- Could you tell us a little about the spectrum of Pompe disease and the impact on daily life for people living with Pompe disease? (026)
- You’re involved in the newborn screening program for Pompe disease – why is this important for people with the disease? (2:15)
- With new therapies prolonging survival, what more is needed to support people living with Pompe to realise their life goals? (6:22)
Disclosures: Damara Ortiz has received research and grant support from Sanofi-Genzyme and Amicus.
Support: The production of this video was supported by Touch Medical Media.
Other content available in support of Rare Disease Day includes:
Share this Video
Related Videos In Heart Failure
ESC Congress 2023 Amsterdam: Ross Campbell, OPERA-AI trial, handheld echocardiography in suspected heart failure
Presented at the European Society of Cardiology Congress (ESC Congress) 2023 Amsterdam, the OPERA-AI trial compared the use of handheld echocardiography analysed by artificial intelligence (AI) to ‘cart-based’ echocardiography reported by humans, to help diagnose suspected heart failure. In this touchCARDIO interview, we speak to Dr. Ross Campbell (University of Glasgow, Glasgow, UK) to discuss the […]
ESC Congress 2023 Amsterdam: Robert Mentz, HEART-FID trial, intravenous iron for heart failure with reduced ejection fraction
The HEART-FID trial built on research from the AFFIRM-AHF and IRONMAN trials to investigate the use of intravenous iron in treating heart failure with iron deficiency. In this touchCARDIO interview, we speak to Dr. Robert Mentz (Duke University, NC, US) regarding the HEART-FID trial, presented at the European Society of Cardiology Congress (ESC Congress) 2023 […]
Gregg Stone, ACC 2023: COAPT trial results – Transcatheter edge-to-edge repair with MitraClip device for functional mitral regurgitation in heart failure
The COAPT trial investigated the use of the MitraClip a novel device for patients with secondary mitral regurgitation, a condition in which blood leaks backward through the mitral valve into the left atrium of the heart. In this touchCARDIO interview Dr Gregg Stone (Mount Sinai Heart Health System, New York City, NY, USA) discusses the […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!